title: Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
abstract: BACKGROUND
  The peritoneum is the second most common site of recurrence in colorectal cancer. Early detection of peritoneal carcinomatosis (PC) by imaging is difficult. Patients eventually presenting with clinically apparent PC have a poor prognosis. Median survival is only about five months if untreated and the benefit of palliative systemic chemotherapy is limited. Only a quarter of patients are eligible for curative treatment, consisting of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CR/HIPEC). However, the effectiveness depends highly on the extent of disease and the treatment is associated with a considerable complication rate. These clinical problems underline the need for effective adjuvant therapy in high-risk patients to minimize the risk of outgrowth of peritoneal micro metastases. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) seems to be suitable for this purpose. Without the need for cytoreductive surgery, adjuvant HIPEC can be performed with a low complication rate and short hospital stay.
  
  
  METHODS
  The aim of this study is to determine the effectiveness of adjuvant HIPEC in preventing the development of PC in patients with colon cancer at high risk of peritoneal recurrence. This study will be performed in the nine Dutch HIPEC centres, starting in April 2015. Eligible for inclusion are patients who underwent curative resection for T4 or intra-abdominally perforated cM0 stage colon cancer. After resection of the primary tumour, 176 patients will be randomized to adjuvant HIPEC followed by routine adjuvant systemic chemotherapy in the experimental arm, or to systemic chemotherapy only in the control arm. Adjuvant HIPEC will be performed simultaneously or shortly after the primary resection. Oxaliplatin will be used as chemotherapeutic agent, for 30 min at 42-43 °C. Just before HIPEC, 5-fluorouracil and leucovorin will be administered intravenously. Primary endpoint is peritoneal disease-free survival at 18 months. Diagnostic laparoscopy will be performed routinely after 18 months postoperatively in both arms of the study in patients without evidence of disease based on routine follow-up using CT imaging and CEA.
  
  
  CONCLUSIONS
  Adjuvant HIPEC is assumed to reduce the expected 25 % absolute risk of PC in patients with T4 or perforated colon cancer to a risk of 10 %. This reduction is likely to translate into a prolonged overall survival.
  
  
  BACKGROUND
  NCT02231086 (Clinicaltrials.gov).
authors.affiliation: Department of surgery, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. C.E.Klaver@amc.nl.
authors.forename: Charlotte E L
authors.initials: CE
authors.lastname: Klaver
authors.affiliation: Department of surgery, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. G.D.Musters@amc.nl.
authors.forename: Gijsbert D
authors.initials: GD
authors.lastname: Musters
authors.affiliation: Department of surgery, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. W.A.Bemelman@amc.nl.
authors.forename: Willem A
authors.initials: WA
authors.lastname: Bemelman
authors.affiliation: Department of oncology, Academic Medical Centre, University of Amsterdam, Post box 22660, Amsterdam, The Netherlands. c.punt@amc.uva.nl.
authors.forename: Cornelis J A
authors.initials: CJ
authors.lastname: Punt
authors.affiliation: Department of Surgery, Antoni van Leeuwenhoek hospital/the Netherlands Cancer Institute, Amsterdam, The Netherlands. v.verwaal@nki.nl.
authors.forename: Victor J
authors.initials: VJ
authors.lastname: Verwaal
authors.affiliation: Clinical Research Unit, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. m.g.dijkgraaf@amc.uva.nl.
authors.forename: Marcel G W
authors.initials: MG
authors.lastname: Dijkgraaf
authors.affiliation: Department of Surgery, Antoni van Leeuwenhoek hospital/the Netherlands Cancer Institute, Amsterdam, The Netherlands. a.aalbers@nki.nl.
authors.forename: Arend G J
authors.initials: AG
authors.lastname: Aalbers
authors.affiliation: Department of surgery, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. j.d.w.vanderbilt@gmail.com.
authors.forename: Jarmila D W
authors.initials: JD
authors.lastname: van der Bilt
authors.affiliation: Department of surgery, St. Antonius Hospital, Post box 2500, 3430 EM, Nieuwegein, The Netherlands. d.boerma@antoniusziekenhuis.nl.
authors.forename: Djamila
authors.initials: D
authors.lastname: Boerma
authors.affiliation: Department of surgery, Radboud University Medical Centre, Geert Grooteplein-Zuid 22, 6525 GA, Nijmegen, The Netherlands. andre.bremers@radboudumc.nl.
authors.forename: Andre J A
authors.initials: AJ
authors.lastname: Bremers
authors.affiliation: Department of surgery, Erasmus Medical Centre/Daniel den Hoed, Post box 2040, 3000 CA, Rotterdam, The Netherlands. j.burger@erasmusmc.nl.
authors.forename: Jacobus W A
authors.initials: JW
authors.lastname: Burger
authors.affiliation: Department of surgery, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. c.j.buskens@amc.nl.
authors.forename: Christianne J
authors.initials: CJ
authors.lastname: Buskens
authors.affiliation: Dutch Cancer Patient Organization 'Leven met Kanker', Utrecht, the Netherlands. p.evers@levenmetkanker.nl.
authors.forename: Pauline
authors.initials: P
authors.lastname: Evers
authors.affiliation: Department of surgery, University Medical Centre, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. r.j.van.ginkel@umcg.nl.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: van Ginkel
authors.affiliation: Department of surgery, University Medical Centre, Post box 85500, 3584 CX, Utrecht, The Netherlands. W.M.U.vanGrevenstein@umcutrecht.nl.
authors.forename: Wilhelmina M U
authors.initials: WM
authors.lastname: van Grevenstein
authors.affiliation: Department of surgery, University Medical Centre, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. p.h.j.hemmer@umcg.nl.
authors.forename: Patrick H J
authors.initials: PH
authors.lastname: Hemmer
authors.affiliation: Department of surgery, Catharina Ziekenhuis, Post box 1350, 5602 ZA, Eindhoven, The Netherlands. Ignace.d.hingh@catharinaziekenhuis.nl.
authors.forename: Ignace H J T
authors.initials: IH
authors.lastname: de Hingh
authors.affiliation: Department of pharmacy, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. l.a.tenberg-lammers@amc.nl.
authors.forename: Laureen A
authors.initials: LA
authors.lastname: Lammers
authors.affiliation: Department of surgery, University Medical Centre, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. b.l.van.leeuwen@umcg.nl.
authors.forename: Barbara L
authors.initials: BL
authors.lastname: van Leeuwen
authors.affiliation: Departement of surgery, Vrije University Medical Center, Post box 7057, 1007 MB, Amsterdam, The Netherlands. j.meijerink@vumc.nl.
authors.forename: Wilhelmus J H J
authors.initials: WJ
authors.lastname: Meijerink
authors.affiliation: Department of surgery, Catharina Ziekenhuis, Post box 1350, 5602 ZA, Eindhoven, The Netherlands. simon.nienhuijs@catharinaziekenhuis.nl.
authors.forename: Simon W
authors.initials: SW
authors.lastname: Nienhuijs
authors.affiliation: Society of patients with cancer of the gastrointestinal tract (SPKS), Darmkanker Nederland, Utrecht, the Netherlands. jolienpon@kpnmail.nl.
authors.forename: Jolien
authors.initials: J
authors.lastname: Pon
authors.affiliation: Department of oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 22, 6525 GA, Nijmegen, The Netherlands. sandra.radema@radboudumc.nl.
authors.forename: Sandra A
authors.initials: SA
authors.lastname: Radema
authors.affiliation: Department of surgery, St. Antonius Hospital, Post box 2500, 3430 EM, Nieuwegein, The Netherlands. b.ramshorst@antoniusziekenhuis.nl.
authors.forename: Bert
authors.initials: B
authors.lastname: van Ramshorst
authors.affiliation: Department of pathology, Antoni van Leeuwenhoek hospital/the Netherlands Cancer Institute, Amsterdam, The Netherlands. p.snaebjornsson@nki.nl.
authors.forename: Petur
authors.initials: P
authors.lastname: Snaebjornsson
authors.affiliation: Departement of surgery, Vrije University Medical Center, Post box 7057, 1007 MB, Amsterdam, The Netherlands. j.tuynman@vumc.nl.
authors.forename: Jurriaan B
authors.initials: JB
authors.lastname: Tuynman
authors.affiliation: Departement of surgery, Vrije University Medical Center, Post box 7057, 1007 MB, Amsterdam, The Netherlands. e.tevelde@vumc.nl.
authors.forename: Elisabeth A
authors.initials: EA
authors.lastname: Te Velde
authors.affiliation: Department of surgery, St. Antonius Hospital, Post box 2500, 3430 EM, Nieuwegein, The Netherlands. r.wiezer@antoniusziekenhuis.nl.
authors.forename: Marinus J
authors.initials: MJ
authors.lastname: Wiezer
authors.affiliation: Department of surgery, Radboud University Medical Centre, Geert Grooteplein-Zuid 22, 6525 GA, Nijmegen, The Netherlands. H.deWilt@chir.umcn.nl.
authors.forename: Johannes H W
authors.initials: JH
authors.lastname: de Wilt
authors.affiliation: Department of surgery, Academic Medical Centre, University of Amsterdam, Post box 22660, 1105AZ, Amsterdam, The Netherlands. P.J.Tanis@amc.nl.
authors.forename: Pieter J
authors.initials: PJ
authors.lastname: Tanis
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods; D002985:Clinical Protocols; D003110:Colonic Neoplasms / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D008297:Male; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000556:secondary* / Q000628:therapy*